Hypertension
RSSArticles
-
Researchers Suggest Checking Blood Pressure in Both Arms
After taking two readings, use the higher measurement for diagnosis. Guidelines recommend this practice, but data were lacking.
-
Intensive Blood Pressure Control May Augment Cerebral Blood Flow
Patients with hypertension were randomized to intensive vs. standard blood pressure control and underwent baseline and follow-up cerebral perfusion imaging. Intensive blood pressure treatment was associated with improved cerebral perfusion over time.
-
Omega-3 May Help Lower Blood Pressure
A research review revealed consuming about 2 or 3 grams of the fatty acid per day showed benefit.
-
Report: Pregnancy-Related Hypertensive Disorders Doubled in 12 Years
An estimated one in five births in the United States are affected by various adverse pregnancy outcomes.
-
Association Between Breastfeeding and Blood Pressure at 3 Years of Age
Any breastfeeding, including within the first days of life, was associated with significantly lower systolic blood pressure at age 3 years in participants from the Canadian Healthy Infant Longitudinal Development Cohort Study.
-
USPSTF Weighs in on Key Cardiology Topics
Should clinicians screen asymptomatic older patients for atrial fibrillation? What is the best treatment course for patients without cardiovascular disease risk?
-
Meeting Healthy Benchmarks Could Stave Off Heart Disease for Many Years
Sticking to “Life’s Simple 7” could offset high genetic risk for heart disease.
-
Heart Health and Cognitive Decline: Who Fares Better?
More middle-age men might be living with various cardiovascular risk factors and diseases, but the associated negative effects on cognition could be worse for women of the same age with the same conditions.
-
First-Line Therapy for Hypertension
When comparing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs) to treat hypertension, researchers observed no difference in major cardiovascular events — but a better safety profile for ARBs.
-
First-Line Therapy for Hypertension
When comparing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs) to treat hypertension, researchers observed no difference in major cardiovascular events — but a better safety profile for ARBs.